BRIDGEWAY CAPITAL MANAGEMENT, LLC - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 87 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$986,000
+6.2%
402,300
+76.4%
0.02%
+11.8%
Q2 2021$928,000
-20.3%
228,000
-11.6%
0.02%
-22.7%
Q1 2021$1,164,000
+58.8%
258,000
+73.2%
0.02%
+46.7%
Q4 2020$733,000
-43.3%
149,000
-31.7%
0.02%
-50.0%
Q3 2020$1,293,000
+122.9%
218,0000.0%0.03%
+150.0%
Q2 2020$580,000
+152.2%
218,000
+84.7%
0.01%
+140.0%
Q1 2020$230,000118,0000.01%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 4,172,459$20,528,0001.31%
DELTEC ASSET MANAGEMENT LLC 693,870$3,414,0000.52%
Alpine Global Management, LLC 350,000$1,722,0000.35%
Redmile Group, LLC 2,397,441$11,795,0000.14%
Kamunting Street Capital Management, L.P. 43,833$216,0000.11%
IHT Wealth Management, LLC 250,798$1,234,0000.10%
SEARLE & CO. 34,000$167,0000.08%
GPS Wealth Strategies Group, LLC 46,025$226,0000.08%
ArrowMark Colorado Holdings LLC 1,981,909$9,751,0000.08%
Gladstone Institutional Advisory LLC 51,500$2530.05%
View complete list of XERIS PHARMACEUTICALS INC shareholders